Back to News
Market Impact: 0.2
Consensus Price Target for JD Health International Inc. - Depositary Receipt Increased by 105.71% to $9.32
Source: Nasdaq
Analyst EstimatesHealthcare & Biotech
The average one-year price target for JD Health International Inc. depositary receipts was revised up 105.71% to $9.32 per share from $4.53 on October 21, 2024. The article provides an analyst estimate change but no explanation or reported share-price reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Oncologists Cheer Melanoma Data
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- Investing.com’s stocks of the week
- Jefferies raises Zymeworks stock price target on Roche deal
- Cumberland Pharmaceuticals stock tumbles on trial results